Skip to main content

Doxazosin (International)

In the US, Doxazosin (doxazosin systemic) is a member of the following drug classes: alpha blockers, antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia, High Blood Pressure and Raynaud's Syndrome.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02CA04

CAS registry number (Chemical Abstracts Service)

0074191-85-8

Chemical Formula

C23-H25-N5-O5

Molecular Weight

452

Therapeutic Categories

Antihypertensive agent

α₁-adrenoceptor antagonist (α₁-blocker)

Treatment of symptoms of benign prostatic hyperplasia

Chemical Name

Piperazine, 1-(4-amino-6,7-dimetoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs